JOJarod Olson

Jarod Olson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jarod Olson has a total of 48 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Surgical Risk and Patient-Reported Outcomes in 3- and 4-Level Anterior Cervical Discectomy and Fusion: A Comparative Study

    by Yulia Lee, Jonathan Dalton, Joydeep Baidya, Chloe Herczeg, Mitchell Ng, Alec Giakas, Jarod Olson, Robert J. Oris, Rachel Huang, Joshua Mathew, et al.

    Introduction: The existing literature on anterior cervical diskectomy and fusion (ACDF) predominantly focuses on 1- and 2-level procedures, leaving limited data comparing outcomes of 3- versus 4-level standalone ACDFs. Thus, the aim of this study was to compare surgical outcomes and patient-reported outcome measures (PROMs) of 3- versus 4-level ACDF. Methods: Patients who underwent 3- or 4-level ACDF within a single academic health system (2014 to 2020) were retrospectively identified. Surgical outcomes and PROMs were evaluated, including the 0 to 10 numeric rating scale for neck and arm pain, Short Form-12, Modified Japanese Orthopaedic Association (mJOA), and Neck Disability Index (NDI). Patients were excluded if they did not have complete preoperative or 1-year postoperative mJOA scores, underwent ACDF for tumor/trauma/infection, or had concomitant posterior cervical fusion. Results: A total of 256 patients were included (46 4-level ACDFs). Patients undergoing 4-level ACDF had higher BMI (30.8 vs. 28.9; P = 0.032) and a greater prevalence of myelopathy (45.7% vs. 33.3%; P = 0.018) but were otherwise demographically similar to 3-level ACDF patients. Four-level ACDF patients had a higher dysphagia rate (20% vs. 8.6%; P = 0.033) and a higher 30-day ED visit rate (6.5% vs. 0%; P = 0.005) but similar readmission rates and all other surgical outcomes. Patients with 4-level ACDF had better 6-month NDI scores but worse 1-year mJOA scores. All other PROM comparisons and deltas were similar at all time points. Conclusion: Patients undergoing 4-level ACDF had higher BMI and a greater prevalence of myelopathy than those undergoing 3-level ACDF; 4-level ACDF was associated with a higher rate of dysphagia and early postoperative ED utilization, but not readmissions. The groups otherwise did similarly with respect to surgical outcomes and PROM improvements. These findings suggest that extending fusion from three to four levels was not associated with increased surgical risk or inferior short-term functional or pain outcomes compared with 3-level ACDF.

  • Open Access

    Well-controlled asthma does not adversely affect outcomes following anterior cervical discectomy and fusion

    by Mitchell Ng, Gregorio Baek, Yulia Lee, Chloe Herczeg, Jonathan Dalton, Matthew Meade, Mark Miller, Joydeep Baidya, Jarod Olson, Robert J. Oris, et al.

    Study Design: Retrospective Cohort Study. Objective: Recent studies have explored the negative impact that respiratory conditions have on outcomes after anterior discectomy and fusion (ACDF). However, the impact that asthmatic status has on postoperative outcomes remains unclear. The purpose of this study was to compare postoperative outcomes between patients with and without asthma who undergo ACDF. Methods: Patients who underwent a primary, elective 1–4 level ACDF (2014–2020) with complete preoperative and 1-year postoperative Neck Disability Index (NDI) surveys were identified. Asthmatic status was determined and stratified into severity. Demographic, comorbidity, perioperative, and PROM data were collected. PROMs included the Visual Analog Scale (VAS) Neck and Arm, Mental Component Summary (MCS), Physical Component Summary (PCS), Modified Japanese Orthopaedic Association (mJOA) score, and NDI. Each PROM was assessed preoperatively and postoperatively at 12 months, with P < 0.05 considered significant. Results: 1195 patients were included (81 (6.78%) had a history of asthma and 1114 (93.2%) did not). Of the asthmatic patients, 37 (45.8%) had well-controlled asthma and 44 (54.3%) had controlled asthma. Asthmatic patients were younger (52.7 vs. 56.1, P = 0.008) and had higher CCI scores (1.04 vs. 0.52, P < 0.001). There were no other differences in demographic variables, ED or readmission rates, 1-year reoperation rates, or PROMs between groups. Conclusion: Patients with well-controlled asthma performed equally as well after anterior cervical fusion as those without asthma. Both groups had similar clinical and patient-reported outcomes, suggesting that having a preoperative diagnosis of well-controlled asthma does not increase risk of postoperative complications after ACDF. Level of Evidence: III.

  • Open Access

    The impact of operative level on reoperation rates and short-term patient-reported outcomes in 3-level anterior cervical discectomy and fusion

    by Yulia Lee, Chloe Herczeg, Mitchell K. Ng, Jonathan Dalton, Rachel Huang, Joydeep Baidya, Jarod Olson, Robert J. Oris, Rajkishen Narayanan, William Green, et al.

    Purpose: To examine whether clinical outcomes and patient-reported outcomes (PROMs) differ when patients are stratified by operative level in 3-level ACDF procedures. Methods: In this retrospective single-institution cohort study, patients undergoing 3-level ACDF (2014–2020) were reviewed for demographics, clinical outcomes, and PROMs. Patients with operative indications of infection/cancer/trauma/deformity were excluded. Patients with incomplete preoperative or 1-year postoperative PROMs were also excluded. PROMs, including SF-12, VAS Neck, VAS Arm, mJOA, and NDI, were assessed preoperatively and at 3, 6, and 12 months postoperatively. One-year MCID achievement was calculated using established thresholds. Patients were stratified and compared by construct level (C3-C6, C4-C7, and C5-T1). Results: Patients undergoing C3–C6 fusions were older than those in the C4–C7 group (62.7 versus 58.1 years, P = 0.007). The C5–T1 cohort had a higher 2-year reoperation rate compared to the C4–C7 cohort (18.2% versus 0.77%, P = 0.048). Baseline VAS Arm scores were worse in the C4–C7 group, with greater improvement at 1 year compared to the C3–C6 group (–3.45 versus − 2.27, P = 0.047). A transient difference in NDI at 3 months resolved by 6 months. MCID achievement rates across all PROMs did not differ significantly between groups. Conclusion: In patients undergoing 3-level ACDF, the operative level was associated with reoperation rates and baseline symptom profiles. However, the likelihood of achieving clinically meaningful improvements was similar across levels. Our findings support the need for construct-specific preoperative counseling while reinforcing the overall efficacy of 3-level ACDF across cervical levels.

  • Patients taking GLP-1 agonists for weight-loss prior to posterior lumbar decompression and fusion have similar surgical and patient-reported outcomes

    by Joydeep Baidya, Jonathan Dalton, Gregorio Baek, Adam Fano, Robert J. Oris, Rachel Huang, Chloe Herczeg, Jarod Olson, Mitchell Ng, William A. Green, et al.


  • The Impact of Central and Foraminal Stenosis Severity on the Need for Surgery After Epidural Steroid Injection

    by Jonathan Dalton, Yulia Lee, Jarod Olson, Rajkishen Narayanan, Nicholas M. Wang, Mitchell Ng, Matthew Meade, Alec Giakas, Alexa Tomlak, Delano Trenchfield, et al.

    Study Design: Retrospective Cohort Study. Objective: This study aimed to identify radiographic and patient-dependent factors that predict failure of epidural steroid injection (ESI) management, leading to subsequent surgical management in patients with lumbar stenosis. Summary of Background Data: Lumbar stenosis is a common cause of radiculopathy and neurogenic claudication, and ESIs are a mainstay of conservative care. However, the benefits of ESIs are debated, and limited evidence exists on how stenosis characteristics correlate with the need for eventual surgery post-ESI. Methods: Adult patients (N=581) who received ESIs for lumbar radiculopathy or spinal stenosis between 2018 and 2021 were retrospectively identified. Subsequent lumbar spine surgery within two years of the first ESI was the primary outcome. Central and foraminal stenosis were graded using preoperative MRIs according to the Guen and Lee classification systems, respectively. Pre- and post-injection pain scores were collected. Multivariate logistic regression was used to determine significant independent predictors of subsequent surgery, accounting for age, body mass index (BMI), diabetes, Charlson Comorbidity Index (CCI), total number of ESIs, central stenosis, and foraminal stenosis. Results: Significant predictors of needing surgery within two years of the first ESI were age (OR 0.96; P P =0.046), diabetes (OR 2.55, 95% CI [1.31, 4.96], P =0.010), total number of ESIs received (OR 1.83, 95% CI [1.46, 2.29], P P <0.001). Central stenosis severity was not a significant predictor of surgery following ESI. Conclusions: In patients treated with initial ESI, foraminal stenosis severity predicted the need for subsequent lumbar spine surgery. Additionally, age, BMI, diabetes, and cumulative number of ESIs were identified as independent predictors of surgery. These findings may assist physicians in counseling patients about the progression of their lumbar stenosis and in predicting the need for future surgery. Level of Evidence: III